Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,389 hedge funds and large institutions have $51.8B invested in Celgene Corp in 2019 Q1 according to their latest regulatory filings, with 269 funds opening new positions, 330 increasing their positions, 635 reducing their positions, and 179 closing their positions.
176% more funds holding in top 10
Funds holding in top 10: 41 → 113 (+72)
54% more capital invested
Capital invested by funds: $33.5B → $51.8B (+$18.3B)
50% more first-time investments, than exits
New positions opened: 269 | Existing positions closed: 179
5% more funds holding
Funds holding: 1,317 → 1,389 (+72)
48% less repeat investments, than reductions
Existing positions increased: 330 | Existing positions reduced: 635
57% less call options, than puts
Call options by funds: $2.4B | Put options by funds: $5.53B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$856M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$737M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$704M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$687M |
| 5 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
+$591M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$611M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$518M |
| 3 |
Jennison Associates
New York
|
-$500M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$495M |
| 5 |
Millennium Management
New York
|
-$286M |
CELG Hedge Fund Activity: Q1 2019 in Review
1,389 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q1 2019, worth a combined $51.8B — up 54% from $33.5B a quarter earlier.
Buyers outnumbered sellers: 269 funds opened new CELG positions and 179 closed out — a net gain of 90 holders — while 330 added to existing stakes and 635 trimmed.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $856M. The largest seller was ClearBridge Investments, cutting an estimated $611M.
- 1,389 institutional investors held Celgene Corp (CELG) as of Q1 2019, up from 1,317 in Q4 2018.
- Funds reported $51.8B of Celgene Corp stock for Q1 2019, up 54% quarter-over-quarter.
- 269 funds opened new Celgene Corp positions in Q1 2019 and 179 closed out, a net change of +90 holders.
- The largest Celgene Corp buyer in Q1 2019 was Pentwater Capital Management, an estimated $856M added.
- The largest Celgene Corp seller in Q1 2019 was ClearBridge Investments, an estimated $611M sold.
Based on aggregated 13F filings for Q1 2019.